BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2524965)

  • 1. Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis.
    Raman BK; Van Slyck EJ; Riddle J; Sawdyk MA; Abraham JP; Saeed SM
    Am J Clin Pathol; 1989 Jun; 91(6):647-55. PubMed ID: 2524965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
    Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
    Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A formula for correcting for the in vitro release of platelet beta-thromboglobulin.
    van Wyk V; Heyns AD; de Wet JI; Kotzé HF; Lötter MG
    Thromb Res; 1987 Jun; 46(5):659-68. PubMed ID: 2957816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
    Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease.
    Rueda F; Piñol G; Marti F; Pujol-Moix N
    Acta Haematol; 1991; 85(1):12-5. PubMed ID: 1826402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
    Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redistribution of alpha-granules and their contents in thrombin-stimulated platelets.
    Stenberg PE; Shuman MA; Levine SP; Bainton DF
    J Cell Biol; 1984 Feb; 98(2):748-60. PubMed ID: 6229546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function and its clinical significance in the myelodysplastic syndromes.
    Zeidman A; Sokolover N; Fradin Z; Cohen A; Redlich O; Mittelman M
    Hematol J; 2004; 5(3):234-8. PubMed ID: 15167910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
    Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
    Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases.
    Cunietti E; Gandini R; Mascaro G; Ferrari M; Pappalepore V; Scapellato L
    Scand J Haematol; 1981 Apr; 26(4):339-44. PubMed ID: 6461058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet activation during exacerbation of bronchial asthma--thrombin induced ATP release from washed platelets and plasma beta-TG, PF4, beta-TG/PF4 ratio].
    Yasuba H; Kino T; Fukuda K; Matsui Y; Izumi T; Oshima S; Chihara J
    Arerugi; 1988 Dec; 37(12):1152-60. PubMed ID: 2977722
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of platelet specific proteins and other factors to atherosclerosis in various stages of hypertension.
    Ding YA; Chou TC; Huan R; Lin KC
    Clin Exp Hypertens A; 1991; 13(8):1329-41. PubMed ID: 1836985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis and thrombocythemia: qualitative platelet abnormalities.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1265-72. PubMed ID: 2629455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function.
    Levy-Toledano S; Caen JP; Breton-Gorius J; Rendu F; Cywiner-Golenzer C; Dupuy E; Legrand Y; Maclouf J
    J Lab Clin Med; 1981 Dec; 98(6):831-48. PubMed ID: 6458643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on platelet function in diabetes mellitus.
    Kubisz P; Arabi A; Holan J; Cronberg S
    Haemostasis; 1984; 14(4):347-53. PubMed ID: 6238882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
    Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
    Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
    Hochhaus A; Mindner K; Ostermann G; Höche D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet ultrastructural and functional studies in myelodysplasia.
    Blockmans D; Heynen MJ; Verhoef GE; Vermylen J
    Haematologia (Budap); 1995; 26(3):159-72. PubMed ID: 7797146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.